What is the long-term outcome of patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies?
A study from the REAL registry found that patients treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies had similar long-term outcomes in terms of mortality and major adverse cardiac events (MACE). Additionally, there was no significant difference in outcomes between staged and one-time multivessel percutaneous intervention in patients with ST-segment elevation myocardial infarction according to the HORIZONS-AMI trial.